Clinical Trial Update: Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on reproducibility of intratumor distribution of 18F-EF5 in head and neck cancer (squamous cell carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• 18F-EF5

Snippet

Sponsor: Turku University Hospital | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2019-10-04